Butterfly Network Inc Revenue Growth Rates (BFLY), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Butterfly Network Inc   (NYSE: BFLY)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

BFLY's Revenue Growth by Quarter and Year

Butterfly Network Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BFLY Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 32.61
1st Quarter March 26.29
FY 58.90

BFLYs Annual Revenue
Butterfly Network Inc 's Revenue in the fiscal year 2025 $ 96.73 millions
Butterfly Network Inc 's Revenue in the fiscal year 2024 $ 81.83 millions
Butterfly Network Inc 's Revenue in the fiscal year 2023 $ 65.86 millions
Butterfly Network Inc 's Revenue in the fiscal year 2022 $ 73.39 millions
Butterfly Network Inc 's Revenue in the fiscal year 2021 $ 62.57 millions




BFLY Revenue second quarter 2026 Y/Y Growth Comment
Butterfly Network Inc achieved in the second quarter 2026, above Company average Revenue rise of 42.47% year on year, to $ 32.61 millions.

Looking into second quarter 2026 results within Medical Laboratories industry 4 other companies have achieved higher Revenue growth. While Butterfly Network Inc ' s Revenue jump of 42.47% ranks overall at the positon no. 538 in the second quarter 2026.


BFLY Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 35.72 % 38.99 % -14.34 %
3rd Quarter September - 4.99 % 31.53 % -19.01 %
2nd Quarter June 42.47 % 11.17 % 14.9 % -6.76 %
1st Quarter March 29 % 17.94 % 11.63 % -0.58 %
FY   - 18.19 % 24.26 % -

Financial Statements
Butterfly Network Inc 's second quarter 2026 Revenue $ 32.61 millions BFLY's Income Statement
Butterfly Network Inc 's second quarter 2025 Revenue $ 22.89 millions Quarterly BFLY's Income Statement


BFLY Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 51.69 % 17.35 % 11.05 %
3rd Quarter September - -7.21 % -1.75 % -14.17 %
2nd Quarter June 24.05 % 12.32 % 19.16 % 15.76 %
1st Quarter March -18.4 % -14.15 % 1.17 % -22.37 %
FY (Year on Year)   - 18.19 % 24.26 % -


Back to BFLY Growth rate Comparisons >> Back to BFLY Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #5
Healthcare Sector #126
Overall #538

Revenue Y/Y Growth Statistics
High Average Low
44.26 % 14.03 % -19 %
(Dec 31 2021)   (Dec 31 2023)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #5
Healthcare Sector #126
Overall #538
Revenue Y/Y Growth Statistics
High Average Low
44.26 % 14.03 % -19 %
(Dec 31 2021)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Butterfly Network Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
54.46 % 5.8 % -24.09 %
(Dec 31 2020)  


BFLY's II. Quarter Q/Q Revenue Comment
Butterfly Network Inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 24.05%, to $ 32.61 millions, from $26.29 millions in the first quarter.
BFLY is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Laboratories industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Butterfly Network Inc 's Revenue growth quarter on quarter, overall rank is 442.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #4
Healthcare Sector #95
Overall #442
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #4
Healthcare Sector #95
Overall #442
Revenue Q/Q Growth Statistics
High Average Low
54.46 % 5.8 % -24.09 %
(Dec 31 2020)  


BFLY's II. Quarter Q/Q Revenue Comment
Butterfly Network Inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 24.05%, to $ 32.61 millions, from $26.29 millions in the first quarter.
BFLY is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Laboratories industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Butterfly Network Inc 's Revenue growth quarter on quarter, overall rank is 442.


Butterfly Network Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 112.36 $ 102.64 $ 96.73 $ 88.25 $ 87.24
Y / Y Revenue Growth (TTM) 28.79 % 20.84 % 18.21 % 17.4 % 24.06 %
Year on Year Revenue Growth Overall Ranking # 698 # 518 # 314 # 528 # 721
Seqeuential Revenue Change (TTM) 9.47 % 6.1 % 9.61 % 1.16 % 2.71 %
Seq. Revenue Growth (TTM) Overall Ranking # 2338 # 1819 # 924 # 660 # 494


Cumulative Revenue growth Comment
Butterfly Network Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 28.79% year on year, to $ 112 millions if the fiscal year would have ended in Jun 30 2026.
Butterfly Network Inc 's trailing twelve months Revenue growth was higher than company's average 12.12% and higher than 20.84% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 9.47 % from $102.64 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at12.12%.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 9.47 % increase from $102.64 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 145 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 518 to 698.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 146
Overall # 698

Revenue TTM Y/Y Growth Statistics
High Average Low
35.27 %
 12.12 %
-10.66 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 337
S&P 500 # 2338
Cumulative Revenue growth Comment
Butterfly Network Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 28.79% year on year, to $ 112 millions if the fiscal year would have ended in Jun 30 2026.
Butterfly Network Inc 's trailing twelve months Revenue growth was higher than company's average 12.12% and higher than 20.84% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 9.47 % from $102.64 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at12.12%.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 9.47 % increase from $102.64 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 145 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 518 to 698.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 146
Overall # 698

Revenue TTM Y/Y Growth Statistics
High Average Low
35.27 %
12.12 %
-10.66 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 337
S&P 500 # 2338




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BFLY's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Madrigal Pharmaceuticals Inc 71.17%$ 71.169 millions
Tg Therapeutics Inc 70.27%$ 70.272 millions
Tarsus Pharmaceuticals Inc 69.41%$ 69.406 millions
Hyperfine Inc 67.70%$ 67.698 millions
Alnylam Pharmaceuticals Inc 66.86%$ 66.856 millions
Emergent Biosolutions Inc 66.29%$ 66.288 millions
Vivos Therapeutics Inc 65.69%$ 65.691 millions
Iovance Biotherapeutics inc 65.65%$ 65.654 millions
Billiontoone Inc 64.40%$ 64.403 millions
Anteris Technologies Global Corp 63.27%$ 63.269 millions
Nexgel Inc 63.24%$ 63.242 millions
Carlsmed Inc 59.58%$ 59.575 millions
Sonoma Pharmaceuticals Inc 59.55%$ 59.552 millions
Arcutis Biotherapeutics Inc 59.33%$ 59.331 millions
Nephros Inc 58.55%$ 58.551 millions
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions
Beyond Air Inc 52.94%$ 52.941 millions
Caredx Inc 52.23%$ 52.226 millions
Bioxcel Therapeutics Inc 51.67%$ 51.667 millions
Glaukos Corp50.63%$ 50.628 millions
Heartflow Inc 49.80%$ 49.801 millions
Coya Therapeutics Inc 48.97%$ 48.974 millions
Travere Therapeutics Inc 48.17%$ 48.174 millions
Halozyme Therapeutics Inc 47.67%$ 47.673 millions
Eli Lilly And Company47.67%$ 47.670 millions
Rhythm Pharmaceuticals Inc 46.91%$ 46.911 millions
Axsome Therapeutics Inc 45.54%$ 45.543 millions
Guardant Health Inc 44.33%$ 44.332 millions
Omada Health Inc 43.27%$ 43.273 millions


About Butterfly Network Inc Revenue Growth Rates (BFLY), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.